1346134-72-2

Upstream product

• 1346136-06-8 methyl 4-[2-(4-{[(2-amino-4,5,6,7-tetrahydro-1-benzothiophen-3-yl)carbonyl]amino}phenyl)ethyl]benzoate 
• 1346136-05-7 methyl 4-[2-(4-{[cyano(cyclohexylidene)acetyl]amino}phenyl)ethyl]benzoate 
• 1346136-03-5 methyl 4-(2-{4-[(cyanoacetyl)amino]phenyl}ethyl)benzoate 
• 1346136-01-3 methyl 4-[2-(4-aminophenyl)ethyl]benzoate 
• 136827-59-3 methyl 4-[(E)-2-(4-nitrophenyl)ethenyl]benzoate 
• 1571-08-0 methyl 4-formylbenzoate 
• 1346136-07-9 methyl 4-[2-(4-{[(2-{[3-(chlorosulfonyl)benzoyl]amino}-4,5,6,7-tetrahydro-1-benzothiophen-3-yl)carbonyl]amino}phenyl)ethyl]benzoate 
• 6937-16-2 ethyl γ-aminobutyrate hydrochloride 
• 2609-49-6 diethyl p-nitrobenzylphosphonate 

Downstream Products

• 1346134-45-9 methyl 4-{2-[4-({[2-({3-[(4-ethoxy-4-oxobutyl)(ethyl)sulfamoyl]benzoyl}amino)-4,5,6,7-tetrahydro-1-benzothiophen-3-yl]carbonyl}amino)phenyl]ethyl}benzoate 

Relevant academic research and scientific papers

TETRAHYDROBENZOTHIOPHENE COMPOUND

The purpose is to provide a compound which has an intestinal phosphate transporter (NPT-IIb) inhibitory action and is useful as an active ingredient of an agent for treating and/or preventing hyperphosphatemia. A tetrahydrobenzothiophene compound of the following formula (I) has NPT-IIb inhibitory action and can be used as an agent for treating and/or preventing hyperphosphatemia: wherein, R1 represents -O-lower alkyl, -lower alkylene-phenyl, or the like; R2 and R3 are the same as or different from each other and represent H, lower alkyl, cycloalkyl, aryl, heteroaryl or the like, or, R2 and R3 may be combined with a nitrogen atom to which they bind to form 5- to 7-membered saturated cyclic amino; R4,s are the same as or different from each other and represent halogen, lower alkyl; and n represents 0 to 2.